News

In this episode, I talk about how news media shapes the stories we hear about drugs and overdose, and why that matters for public understanding and policy. I break down how media coverage determines which overdose stories get attention, how people and communities are portrayed, and how narratives can be amplified, even when they aren’t…

In this episode, I introduce listeners to Season 14 of Aced It, and I talk about how stigma shapes the way we understand drugs, overdose, and addiction, and why the stories we tell about these issues matter. I break down what stigma is, how it operates, and how it influences everything from help -seeking to…

In the final episode this season, I explore holistic, non-pharmacological approaches to addressing opioid use disorder and overdose, including acupuncture, yoga, mindfulness-based therapies, nutrition, and exercise. I highlight evidence showing how these practices support traditional treatments by reducing stress, improving emotional regulation, alleviating pain, and lowering relapse risk. Download the one-pager (PDF). This project was…

In this episode, I explore how long-acting injectable medications, like Vivitrol, Sublocade, and Brixadi, are reshaping treatment for opioid use disorder by reducing daily dosing burdens and improving treatment adherence. I review evidence on their clinical effectiveness, patient experiences, and the practical and ethical considerations involved in implementing these medications in both community and carceral…

In this episode, I examine how digital and telehealth tools, from smartphone apps and wearable sensors to virtual overdose-monitoring services, are being used to address opioid use disorder and overdose risk. I explore what the research says about their effectiveness, how people who use drugs perceive them, and the challenges of making these technologies accessible,…

In this episode, I explore the growing scientific interest in psychedelic-assisted therapy as a potential treatment for substance use disorders, particularly opioid addiction. I trace the historical roots of psychedelic therapy, review emerging evidence on substances like lysergic acid diethylamide (LSD), ketamine, psilocybin, and ibogaine, and highlight the challenges of translating promising findings into safe,…

In this episode, I talk about the emerging practice of safer supply and prescribed alternatives, highlighting how Canada has implemented these programs to reduce overdose deaths and support people who use drugs. I walk listeners through evidence on outcomes, participant and provider perspectives, and key lessons for U.S. states beginning to explore safer supply models.…

In this episode, I talk about how peer support and recovery groups contribute to treatment engagement, overdose prevention, and long-term recovery for people with opioid use disorder. I discuss studies showing that strong involvement in 12-step programs can enhance psychological well-being and that peer-led outreach is effective in connecting individuals to care. I also highlight…

In this episode, I talk about the role of outpatient counseling and overdose response in supporting people with opioid use disorders (OUDs). I begin by discussing why outpatient services are central to recovery and how they often function as the first and most common point of care. I review research showing that many outpatient programs…